OPTIMISING RURAL MUSCULOSKELETAL HEALTH
Adnan Asger Ali, PhD candidate
The University of Sydney &
Director & Principal Physiotherapist
Accelerate Physiotherapy, Canberra, Australia &
Chair of Business and Finance Committee,
International Federation of Manual and Musculoskeletal Physical Therapists Incorporated (IFOMPT) &
Chair, National Musculoskeletal Committee,
Australian Physiotherapy Association
RESEARCHER PROFILE
Filmed in Canberra, Australia | September 2025
Adnan Asger Ali is a Director of Accelerate Physiotherapy and PhD candidate at The University of Sydney, where he is researching implementation strategies for musculoskeletal care pathways in rural Australia as part of the PACE-RURAL project.
Graduating from The University of Canberra, Adnan completed a Masters in Musculoskeletal Physiotherapy at La Trobe University and a Masters in Pain Management at The University of Sydney. He is one of few physiotherapists in Australia holding dual APA titles as both Musculoskeletal and Pain Physiotherapist.
A passionate advocate for physiotherapy, Adnan serves as Chair of the Australian Physiotherapy Association’s National Musculoskeletal Committee and sits on the Capital Health Network’s Clinical Council. His commitment to clinical excellence was recognised when he received Physiotherapist of the Year at the 2023 Allied Health Awards.
Adnan has extensive sports physiotherapy experience, currently working with Tennis Australia treating professional players on international tours and at The Australian Open. Through his research and clinical practice, he is dedicated to improving access to evidence-based musculoskeletal care for all Australians.
Source: Supplied
-
Touched by bowel cancer and chasing science outcomes
Dr Josephine Wright is a Senior Research Fellow in the Gut Cancer group. She has been developing a translational network of labs, hospitals and clinics to enable validation of new approaches to prevent and treat colorectal and gastric cancer. Her key focus is studying human tumour organoids to better personalise therapy in cancer.
-
World-first clinical trial improves patient outcomes for kidney transplants (2023)
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Around one in three people who receive a kidney transplant suffer delayed graft function, which means the transplant doesn’t work immediately and they require dialysis.
The lead-author of the study, was Royal Adelaide Hospital Nephrologist and University of Adelaide researcher, Dr Michael Collins.
-
Corneal and Ocular Surface Immunology and Regeneration
Assoc Professor Holly Chinnery’s career in ocular immunology began with a focus on animal models; however, it has recently transitioned into clinical imaging studies involving human research participants. The ability to visualise the immune system and sensory nerves in the human cornea represents a significant advantage in corneal immunology and neuroimmunology research.
